Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6317)
All Articles published online
|
Publishing Process of This Article
|
Feb 16, 2021 (publication date) through May 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang Y, Fu LJ, Chen CM, Hu MW. Venetoclax in combination with chidamide and dexamethasone in relapsed/refractory primary plasma cell leukemia without t(11;14): A case report. World J Clin Cases 2021; 9(5): 1175-1183 [PMID: 33644182 DOI: 10.12998/wjcc.v9.i5.1175] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i5/1175.htm |
| Number | Citing Articles |
| 1 |
Hesham Elsabah, Rola Ghasoub, Halima El Omri, Maria Benkhadra, Honar Cherif, Ruba Y. Taha. Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1390747
|
| 2 |
Han‐Yu Cao, Ling Li, Sheng‐Li Xue, Hai‐Ping Dai. Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy. Hematological Oncology 2023; 41(3): 301 doi: 10.1002/hon.3088
|
| 3 |
|
| 4 |
Grigorios Alvanidis, Dimitrios Kotsos, Christina Frouzaki, Amalia Fola, Evdoxia Hatjiharissi. The potential role of BCL-2 inhibition in amyloidosis and plasma cell leukemia. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1549891
|
| 5 |
Maria Dampmann, Sarah Flossdorf, Julius Keyl, Hans Christian Reinhardt, Christine Hanoun. Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics. Acta Haematologica 2024; : 1 doi: 10.1159/000539223
|
| 6 |
Zimu Gong, Meera Khosla, Sreeraj Vasudevan, Meera Mohan. Current Status on Management of Primary Plasma Cell Leukemia. Current Oncology Reports 2024; 26(9): 1104 doi: 10.1007/s11912-024-01563-0
|